Entera Bio
ENTX
3 hedge funds and large institutions have $3.78M invested in Entera Bio in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
4.88% less ownership
Funds ownership: 15.81% → 10.94% (-4.9%)
5% less capital invested
Capital invested by funds: $3.99M → $3.78M (-$209K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$192K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Knoll Capital Management
Miami,
Florida
| $3.27M | – | – | – |
|
|
WCM
2
Wildcat Capital Management
New York
| $369K | – | – | – |
|
|
PF
3
Phoenix Financial
Givatayim,
Israel
| $138K | +$192K | +69,355 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$1K | -620 | Closed |
|
ENTX Hedge Fund Activity: Q1 2020 in Review
3 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q1 2020, worth a combined $3.78M — down 5.2% from $3.99M a quarter earlier.
Fund positioning in ENTX was balanced in Q1 2020: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Phoenix Financial, opening a new position worth an estimated $192K. The largest seller was UBS Group, exiting entirely with an estimated $1K sold.
- 3 institutional investors held Entera Bio (ENTX) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $3.78M of Entera Bio stock for Q1 2020, down 5.2% quarter-over-quarter.
- 1 fund opened new Entera Bio positions in Q1 2020 and 1 closed out, a net change of 0 holders.
- The largest Entera Bio buyer in Q1 2020 was Phoenix Financial, an estimated $192K added.
- The largest Entera Bio seller in Q1 2020 was UBS Group, an estimated $1K sold.
Based on aggregated 13F filings for Q1 2020.